reports
Blue Line Protection Group Provides Financial Review
Blue Line Protection Group Provides Financial Review Denver, CO, April 24, 2024 (GLOBE NEWSWIRE) -- Blue Line Protection Group Inc. (OTCQB: BLPG) is pleased to summarize the 2023 financial results. 2023 was a profitable year for the Company, as shown in our 10K filing. Revenue grew by 13% respectively, and operating income rose to an impressive $762,713. Total assets grew by $478,493 and shareholders deficit was reduced by $518,470. Additionally, the Company processed over $1,400,000,000 in cash pickups throughout 2023, with that number anticipated to increase in 2024. As our presence an...
ADT Names Jeff Likosar as Chief Financial Officer
ADT Names Jeff Likosar as Chief Financial Officer BOCA RATON, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- (NYSE: ADT), the most trusted brand in smart home and small business security, announced today that Jeff Likosar has been named Chief Financial Officer. In addition to his duties as President, Corporate Development and Chief Transformation Officer, which he will retain, Likosar had been serving as interim CFO since December 2023. He previously served as the company’s CFO from 2017 to 2022. Along with customary CFO responsibilities, Likosar will remain responsible for corporate develo...
INNOVATE Corp. Announces Closing of Rights Offering
INNOVATE Corp. Announces Closing of Rights Offering NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today the closing of its successful rights offering, which expired at 5:00 p.m., New York City time, on April 19, 2024. Pursuant to the terms of the rights offering, 5.2 million shares of common stock are being purchased pursuant to the exercise of basic subscription rights and 0.1 million additional shares of common stock are being purchased under the over-subscription privilege. In accordance...
Mueller Water Products Announces Dates for Second Quarter 2024 Earning...
Mueller Water Products Announces Dates for Second Quarter 2024 Earnings Release and Conference Call ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA) plans to release financial results for its second quarter ended March 31, 2024, after U.S. markets close on Monday, May 6, 2024. On Tuesday, May 7, 2024, at 10:00 a.m. ET, the Company will hold a conference call to discuss earnings and business results. Interested parties are invited to listen via webcast available on the Investor Relations section of the Company’s website . An archive of the webcast will b...
Amedisys Reports First Quarter 2024 Financial Results
Amedisys Reports First Quarter 2024 Financial Results BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended March 31, 2024 and 2023 Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023. Prior year included $15.0 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc. of $14.4 million, which is inclusive of merger-relat...
CVB Financial Corp. Reports Earnings for the First Quarter 2024
CVB Financial Corp. Reports Earnings for the First Quarter 2024 First Quarter 2024 Net Earnings of $48.6 million, or $0.35 per share Return on Average Assets of 1.21%Return on Average Tangible Common Equity of 15.13% Net Interest Margin of 3.10% ONTARIO, CA, April 24, 2024 (GLOBE NEWSWIRE) -- CVB Financial Corp. (NASDAQ:CVBF) and its subsidiary, Citizens Business Bank (the “Company”), announced earnings for the quarter ended March 31, 2024. CVB Financial Corp. reported net income of $48.6 million for the quarter ended March 31, 2024, compared with $48.5 million ...
Riot Announces First Quarter 2024 Earnings Conference Call
Riot Announces First Quarter 2024 Earnings Conference Call Castle Rock, CO, April 24, 2024 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) (“Riot” or “the Company”), an industry leader in vertically integrated Bitcoin (“BTC”) mining, announced today that it has scheduled its first quarter 2024 earnings conference call for Wednesday, May 1, 2024, at 8:30 A.M. EST. During the call, Riot will discuss the results for the quarter ended March 31, 2024. This conference call will be available through the audio webcast, please use this link . Additionally, participants can join the con...
NKGen Biotech Announces Upcoming Publication at the 2024 American Soci...
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting SANTA ANA, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer (“NK”) cell therapeutics, today announced an online publication at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to be held virtually and at the McCormick Place Convention Center...
Kroger Co: 4 directors
Four Directors at Kroger Co sold after exercising options/sold 131,705 shares at between 55.520USD and 57.180USD. The significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the com...
- ABGSC IT Research
- Øystein Elton Lodgaard
- ABGSC Online Gaming Research
- Oscar Rönnkvist
- Simon Jönsson
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financi...
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged survival in Study 102 reinforces pivotal NANORAY-312 trial design in head and neck cancer; initial efficacy and favorable safety profile supports potential of NBTXR3 in pancreatic cancer; determined RP2D for MD Anderson lung studyMultiple clinical readouts expected in 2024 including immunotherapy combination data from Study 1100, and data ...
NANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FIN...
NANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FINANCIERS POUR L’ANNÉE 2023 L’accord de licence globale de co-développement et de commercialisation avec Janssen Pharmaceutica NV (« Janssen ») étend le potentiel du radioenhancer NBTXR3 à l’échelle internationale.La survie prolongée observée dans l’Étude 102 soutient la conception de l’essai pivot NANORAY-312 dans le cancer de la tête et du cou. Les premiers signes d’efficacité et le profil de sécurité favorable renforcent le potentiel de NBTXR3 dans le cancer du pancréas. La dose recommandée pour la Phase 2 a été détermin...
First Internet Bancorp Reports First Quarter 2024 Results
FISHERS, Ind.--(BUSINESS WIRE)-- First Internet Bancorp (the “Company”) (Nasdaq: INBK), the parent company of First Internet Bank (the “Bank”), announced today financial and operational results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Net income of $5.2 million and diluted earnings per share of $0.59, increases of 25.1% and 22.9%, respectively, from the fourth quarter of 2023 Net interest income of $20.7 million and fully-taxable equivalent net interest income of $21.9 million, increases of 4.7% and 4.2%, respectively, from the fourth quarter ...
Pfizer Declares Second-Quarter 2024 Dividend
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 second-quarter 2024 dividend on the company’s common stock, payable June 14, 2024, to holders of the Common Stock of record at the close of business on May 10, 2024. The second-quarter 2024 cash dividend will be the 342nd consecutive quarterly dividend paid by Pfizer. About Pfizer: Breakthroughs That Change Patients’ Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the stan...
Advisory: Fortis Inc. to Hold Teleconference on May 1 to Discuss First...
Advisory: Fortis Inc. to Hold Teleconference on May 1 to Discuss First Quarter 2024 Results and Hold Annual and Special Meeting on May 2 ST. JOHN'S, Newfoundland and Labrador, April 24, 2024 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE: FTS) will release its first quarter 2024 financial results on Wednesday, May 1, 2024. A teleconference and webcast will be held the same day at 8:30 a.m. (Eastern). David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Corporation's first q...
Woodward Announces Declaration of Dividend
Woodward Announces Declaration of Dividend FORT COLLINS, Colo., April 24, 2024 (GLOBE NEWSWIRE) -- Woodward, Inc. (NASDAQ:WWD) today announced that its Board of Directors declared a cash dividend of $0.25 per share for the quarter, payable on June 05, 2024, for stockholders of record as of May 22, 2024. About Woodward, Inc. Woodward is the global leader in the design, manufacture, and service of energy conversion and control solutions for the aerospace and industrial equipment markets. Together with our customers, we are enabling the path to a cleaner, decarbonized world. Our innovative...
BioAtla Announces Upcoming Poster Presentation at the 2024 American So...
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced a poster presentation at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to be held virtually and at the McCormick Place Convention Center in Chicago, Illinois from May 31–June 4, 2024....
Hapbee Announces Closing of Private Placement
Hapbee Announces Closing of Private Placement Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- , Inc. (TSXV: ) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company is pleased to confirm that it has completed a non-brokered private placement of units of the Company (“Units”) for aggregate gross proceeds to the Company of CAD$2,785,000 (the “Offering”). “This capital enables us to continue to evolve our products and t...
Moody's Ratings assigns B2 rating to NorthStar's proposed senior secur...
Moody's Ratings (Moody's) assigned a B2 rating to the proposed backed senior secured first lien term loan of NorthStar Group Services, Inc. (NorthStar). All other ratings for NorthStar, including the B2 corporate family rating (CFR), B2-PD probability of default rating and B2 rating on its existing ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.